when fda approve compass pathways' comp360 psilocybin
Before 2028
when fda approve compass pathways' comp360 psilocybin. Best Yes near 91¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 91¢ · Best No: 15¢ · 1 platform
- Kalshi: Yes 91¢ / No 15¢
LIVE
Before 2028
Volume
$232
$38 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jan 1, 2028
~564 days left
Category
Culture
Yes
91¢
Kalshi
No
15¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.
Market Details
ResolutionResolves Jan 1, 2028
Time Left564 days
Status● Active
CategoryCulture
Yes
91¢
Kalshi
Payout 1.1x
No
15¢
Kalshi
Payout 6.7x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In